Coca-Cola Europacific Partners plc (CCEP) has disclosed that Laurence Debroux, its Independent Non-executive Director, has been nominated for appointment to the Supervisory Board of Royal Philips N.V., with the appointment subject to shareholder approval at the Philips 2027 Annual General Meeting. The announcement, made on 16 November 2026, also confirms that Ms. Debroux is nominated to serve as Chair of the Audit Committee at Philips upon appointment. The disclosure was made in accordance with UK Listing Rule 6.4.9R, which requires companies listed on the London Stock Exchange to notify the market of directors' other significant appointments. Investors in CCEP, a constituent of both the NASDAQ 100 and FTSE 100 indices, may note the governance implications of a key board member taking on an additional senior external role.
Key Points
- Coca-Cola Europacific Partners plc (CCEP), listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and the Spanish Stock Exchanges
- Independent Non-executive Director Laurence Debroux has been nominated to the Supervisory Board of Royal Philips N.V.
- Subject to shareholder approval at the Philips 2027 AGM, Ms. Debroux is also nominated as Chair of the Philips Audit Committee
- Investors should watch whether Philips shareholders approve the appointment at the 2027 AGM and monitor any further CCEP board updates
Laurence Debroux Nominated to Royal Philips Supervisory Board as Audit Committee Chair
The announcement states that Ms. Debroux's nomination to the Supervisory Board of Royal Philips N.V. is conditional upon approval by Philips' shareholders at the company's 2027 Annual General Meeting. If approved, she will simultaneously assume the role of Chair of the Audit Committee, effective from the close of that meeting. CCEP has confirmed there are no additional matters requiring disclosure under UK Listing Rule 6.4.9R beyond the notification itself, indicating the company considers the appointment to represent no conflicts requiring further regulatory disclosure at this stage.
CCEP's Board Governance Structure and Debroux's Role as Independent Non-executive Director
Laurence Debroux currently serves as an Independent Non-executive Director at Coca-Cola Europacific Partners, a role that carries responsibilities for independent oversight of management on behalf of shareholders. CCEP is one of the world's largest consumer goods companies, serving nearly 600 million consumers and supporting over 4 million customers across 31 countries. The company operates across a broad geographic footprint, combining multinational scale with local market knowledge. Her nomination to a senior external audit role at a major European corporation such as Royal Philips N.V. underscores the calibre of CCEP's non-executive board membership.
CCEP's Multi-Exchange Listing and Index Membership Provide Broad Investor Scrutiny
Coca-Cola Europacific Partners is currently listed on four exchanges — Euronext Amsterdam, NASDAQ, the London Stock Exchange, and the Spanish Stock Exchanges — and trades under the symbol CCEP with ISIN number GB00BDCPN049. The company is a constituent of both the NASDAQ 100 and FTSE 100 indices, meaning its governance disclosures are subject to scrutiny from a wide and diverse international investor base. Regulatory obligations under UK Listing Rule 6.4.9R require timely notification of directors' external appointments, and CCEP's prompt disclosure reflects standard compliance practice for a company of its scale and listing profile.




Please wait processing your request...